UNIVERSITY OF CALIFORNIA, SAN DIEGO RESEARCHERS IDENTIFY POTENTIAL NEW DRUG TARGET FOR CHRONIC LEUKEMIA
November 24, 2008
November 24, 2008
LA JOLLA, Calif., Nov. 24 -- The University of California at San Diego issued the following press release:
Researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have discovered what could be a novel drug target for an often difficult-to-treat form of leukemia. The investigators have identified a unique "signature" or pattern of a specific family of enzymes in patients with chronic lymphocytic leukemia (CLL), the most common form . . .
Researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have discovered what could be a novel drug target for an often difficult-to-treat form of leukemia. The investigators have identified a unique "signature" or pattern of a specific family of enzymes in patients with chronic lymphocytic leukemia (CLL), the most common form . . .